Inosine
- Generic Name
- Inosine
- Brand Names
- Rejuvesol
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12N4O5
- CAS Number
- 58-63-9
- Unique Ingredient Identifier
- 5A614L51CT
- Background
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
- Indication
The primary popular claim made for inosine, that it enhances exercise and athletic performance, is refuted by the available research data. There is some preliminary evidence that inosine may have some neurorestorative, anti-inflammatory, immunomodulatory and cardioprotective effects.
- Associated Conditions
- -
- Associated Therapies
- Rejuvenation of a unit of RBC
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Emory University
- Target Recruit Count
- 400
- Registration Number
- NCT00139217
- Locations
- 🇺🇸
Emory University affiliated newborn intensive care units, Atlanta, Georgia, United States
Treatment of Multiple Sclerosis Using Over the Counter Inosine
- Conditions
- First Posted Date
- 2003-08-19
- Last Posted Date
- 2006-03-17
- Target Recruit Count
- 30
- Registration Number
- NCT00067327
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
- Conditions
- Interventions
- First Posted Date
- 2000-10-13
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 793
- Registration Number
- NCT00006401
- Locations
- 🇺🇸
Univeristy of Southern California/Good Samaritan Hospital, Los Angeles, California, United States
🇺🇸University of Iowa Hospital & Clinics, Iowa City, Iowa, United States
🇺🇸University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.